Demystifying Quantum Computing: Road Ahead for Commercialization

Demystifying Quantum Computing Road Ahead for Commercialization
In the coming years, quantum computers will likely far exceed the performance of today's supercomputers and as such, will open entirely new opportunities for organizations.The pandemic has underscored the need for CIOs to invest in emerging technologies to both weather this storm and to build a foundation for recovery and future growth. This is evident by tech M&A activity that improved dramatically in the second half of 2020 -- hinting at optimism for the industry, as well as increased and potentially record-breaking levels of movement in the near future. Credit: vchalup via Adobe Stock When it comes to prioritizing such investments, organizations often focus on the core technologies that we frequently hear about: AI, machine learning, 5G, and virtual reality. But there’s another player that has quietly joined the picture with the...

Demystifying Quantum Computing: Road Ahead for Commercialization

Demystifying Quantum Computing Road Ahead for Commercialization
In the coming years, quantum computers will likely far exceed the performance of today's supercomputers and as such, will open entirely new opportunities for organizations.The pandemic has underscored the need for CIOs to invest in emerging technologies to both weather this storm and to build a foundation for recovery and future growth. This is evident by tech M&A activity that improved dramatically in the second half of 2020 -- hinting at optimism for the industry, as well as increased and potentially record-breaking levels of movement in the near future. Credit: vchalup via Adobe Stock When it comes to prioritizing such investments, organizations often focus on the core technologies that we frequently hear about: AI, machine learning, 5G, and virtual reality. But there’s another player that has quietly joined the picture with the...

Prevencio Announces Laboratory Commercialization Partnership with Atlas Genomics Incorporating Microsoft’s AI-computing Cloud

Prevencio Announces Laboratory Commercialization Partnership with Atlas Genomics Incorporating Microsofts AI computing Cloud
Prevencio Announces Laboratory Commercialization Partnership with Atlas Genomics Incorporating Microsoft’s AI-computing Cloud We store cookies on your computer to improve your experience and provide more personalized services, both on this website and on other sites. For more information about the cookies we use, see our Privacy Policy. We won't track your information when you visit our site. We will have to use at least one cookie to ensure that you won't have to make this choice again.AcceptDeclinePrivacy Policy Source...

Prevencio Announces Laboratory Commercialization Partnership with Atlas Genomics Incorporating Microsoft’s AI-computing Cloud

PrevencioLogo
KIRKLAND, Wash.--(BUSINESS WIRE)--Prevencio, Inc. today announces an Agreement with Atlas Genomics to commercially launch its highly accurate, AI-driven HART blood tests for heart disease and risk of heart attack, stroke, and cardiovascular death. The HART blood tests are now available and can be ordered through your physician. Atlas Genomics is a CLIA-certified, high complexity diagnostic lab providing the highest quality of testing, service, and technology. Prevencio’s and Atlas’ partnership incorporates the use of Microsoft’s Azure AI-computing cloud for HART algorithm processing, scoring, report generation and secure physician delivery of Prevencio’s HART test reports. Additional terms of the deal are not disclosed. Technology and commercial laboratory companies have been in heated pursuit of integrating technology, including AI...